Literature DB >> 11702249

Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.

K Sugimachi1, S Maehara, S Tanaka, M Shimada, K Sugimachi1.   

Abstract

Hepatic resection has been regarded as a curative treatment for primary hepatocellular carcinoma (HCC), but a high incidence of postoperative recurrence is general. Thus it is important to predict the patterns of recurrence and select the appropriate treatment for recurrence for a better long-term prognosis of patients with HCC. Clinicopathological studies on 80 patients with intrahepatic recurrence after curative hepatectomy suggested that nodular-type recurrence with up to three nodules is mainly due to metachronous multicentric hepatocarcinogenesis rather than intrahepatic metastases. We reviewed 300 patients with recurrent HCC, and repeat hepatectomy was done in 78 cases (26.0%). The 3- and 5-year survival rates after repeat hepatectomy were 82.8% and 47.5%, respectively, showing better prognosis than those for other treatments. Repeat hepatectomy is the preferred treatment offering a hope of long-term survival for patients with recurrent HCC as long as liver function is sufficient; thus early detection of recurrence should be ensured.

Entities:  

Mesh:

Year:  2001        PMID: 11702249     DOI: 10.1007/s005340100002

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  27 in total

1.  A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yuzo Umeda; Hiroaki Matsuda; Hiroshi Sadamori; Hiroyoshi Matsukawa; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  Laparoscopic repeat resection of recurrent hepatocellular carcinoma.

Authors:  Minggen Hu; Guodong Zhao; Dabin Xu; Rong Liu
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

3.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

4.  Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  Jun Huang; Bin-Kui Li; Gui-Hua Chen; Jin-Qing Li; Ya-Qi Zhang; Guo-Hui Li; Yun-Fei Yuan
Journal:  J Gastrointest Surg       Date:  2009-06-09       Impact factor: 3.452

5.  A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.

Authors:  Cho Rok Lee; Jin Hong Lim; Sung Hoon Kim; Sang Hoon Ahn; Young Nyun Park; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-19       Impact factor: 3.452

6.  The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background.

Authors:  Hui-Chuan Sun; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lu Wang; Qin-Hai Ye; Jia Fan; Zhi-Quan Wu; Xin-Da Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-21       Impact factor: 4.553

7.  Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas.

Authors:  Dongil Choi; Hyo K Lim; Hyunchul Rhim
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 8.  Management of "very early" hepatocellular carcinoma on cirrhotic patients.

Authors:  Gonzalo Sapisochin; Elena Fernandez de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2014-11-27

9.  Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma.

Authors:  Winnie Yeo; Pei-Jer Chen; Junji Furuse; Kwang-Hyub Han; Chiun Hsu; Ho-Yeong Lim; Hanlim Moon; Shukui Qin; Ee-Min Yeoh; Sheng-Long Ye
Journal:  BMC Cancer       Date:  2010-11-10       Impact factor: 4.430

Review 10.  Value of radiofrequency ablation in the treatment of hepatocellular carcinoma.

Authors:  Kai Feng; Kuan-Sheng Ma
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.